3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
4
Rhabdoid Tumor
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Neuroblastoma
4
Medulloblastoma
4
Lymphoma, Non-Hodgkin
4
Lymphoma
4
Histiocytosis, Langerhans-Cell
4
Hepatoblastoma
4
Glioma
4
Ependymoma
4
Sarcoma
3
Rhabdomyosarcoma
3
Osteosarcoma
3
Multiple Myeloma
3
Central Nervous System Neoplasms
3
Sarcoma, Ewing
2
Xanthogranuloma, Juvenile
1
Histiocytic Sarcoma
1
Familial ependymoma
1
Interventions
Paclitaxel
96
Carboplatin
81
Bevacizumab
62
Gemcitabine
36
liposomal doxorubicin
32
pembrolizumab
30
Topotecan
26
olaparib
23
Taxes
23
niraparib
17
Immunoglobulin G
17
Disulfides
17
Docetaxel
16
Cyclophosphamide
16
Cisplatin
14
Nivolumab
11
rucaparib
10
durvalumab
10
Doxorubicin
9
Albumin-Bound Paclitaxel
8
sargramostim
7
pazopanib
7
fludarabine phosphate
7
fludarabine
7
avelumab
7
Magnetic Resonance Spectroscopy
7
Ifosfamide
7
epacadostat
6
Trabectedin
6
Sorafenib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Ovarian Neoplasms
×
Nuclear Medicine Department, Hospital
×
Clear all
No trials found.